Because PD-L1 expression in tumor cells represents a mechanism of immune evasion via the interaction between the PD-L1 ligands on tumor cells and PD-1 on lymphocytes to suppress the immune response, an assessment of PD-1 within tumor-infiltrating lymphocytes is important for understanding the tumor-immune interaction. This evidence concerns the gene CD274 and neoplasm.